Paclitaxel Succinate Analogs: Anionic Introduction as a Strategy to Impart Blood Brain Barrier Permeability
Issue Date
2008Author
Turunen, Brandon J.
Ge, Haibo
Oyetunji, Jariat
Desino, Kelly Elizabeth
Vasandani, Veena
Himes, Richard H.
Audus, Kenneth L.
Seelig, Anna
Georg, Gunda I.
Publisher
Elsevier
Type
Article
Article Version
Scholarly/refereed, author accepted manuscript
Metadata
Show full item recordAbstract
A focused library of TX-67 (C10 hemi-succinate) analogs have been prepared including regioisomeric, functional group, and
one-carbon homologs. These were prepared to investigate TX-67’s lack of interaction with P-glycoprotein (Pgp). Tubulin stabilization
ability, cytotoxicity, and Pgp interactions were evaluated. All carboxylic acid analogs had no apparent interactions with Pgp whereas the
ester variants of the same compounds displayed characteristics of Pgp substrates. Furthermore, it is demonstrated that hydrogen-bonding
properties were significant with respect to Pgp interactions. This anionic introduction strategy may allow for delivery of paclitaxel into
the CNS as well as establishing a new method for delivery of other, non-CNS permeable drugs.
Collections
- Pharmacy Scholarly Works [286]
Citation
Turunen, Brandon et al. (2008). Paclitaxel Succinate Analogs: Anionic Introduction as a Strategy to Impart Blood Brain Barrier Permeability. Bioorganic & Medicinal Chemistry Letters 18(22):5971–5974. www.dx.doi.org/10.1016/j.bmcl.2008.09.103
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.